S100A4 and uric acid promote mesenchymal stromal cell induction of IL-10+/IDO+ lymphocytes

J Immunol. 2014 Jun 15;192(12):6102-10. doi: 10.4049/jimmunol.1303144. Epub 2014 May 2.

Abstract

Simple stress or necrotic cell death with subsequent release of damage-associated molecular patterns (DAMPs) is a characteristic feature of most advanced tumors. DAMPs within the tumor microenvironment stimulate tumor-associated cells, including dendritic cells and mesenchymal stromal cells (MSCs). The presence of tumor-infiltrating MSCs is associated with tumor progression and metastasis. Oxidized necrotic material loses its stimulatory capacity for MSCs. As a DAMP, S100A4 is sensitive to oxidation whereas uric acid (UA) acts primarily as an antioxidant. We tested these two biologic moieties separately and in combination for their activity on MSCs. Similar to necrotic tumor material, S100A4 and UA both dose-dependently induced chemotaxis of MSCs with synergistic effects when combined. Substituting for UA, alternative antioxidants (vitamin C, DTT, and N-acetylcysteine) also enhanced the chemotactic activity of S100A4 in a synergistic manner. This emphasizes the reducing potential of UA being, at least in part, responsible for the observed synergy. With regard to MSC proliferation, both S100A4 and UA inhibited MSCs without altering survival or inducing differentiation toward adipo-, osteo-, or chondrocytes. In the presence of S100A4 or UA, MSCs gained an immunosuppressive capability and stably induced IL-10- and IDO-expressing lymphocytes that maintained their phenotype following proliferation. We have thus demonstrated that both S100A4 and UA act as DAMPs and, as such, may play a critical role in promoting some aspects of MSC-associated immunoregulation. Our findings have implications for therapeutic approaches targeting the tumor microenvironment and addressing the immunosuppressive nature of unscheduled cell death within the tumor microenvironment.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology*
  • Cell Differentiation / drug effects*
  • Cell Differentiation / immunology
  • Dose-Response Relationship, Drug
  • Drug Synergism
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / immunology*
  • Interleukin-10 / immunology*
  • Lymphocytes / cytology
  • Lymphocytes / immunology*
  • Male
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / immunology*
  • S100 Calcium-Binding Protein A4
  • S100 Proteins / agonists
  • S100 Proteins / pharmacology*
  • Uric Acid / agonists
  • Uric Acid / pharmacology*

Substances

  • Antioxidants
  • IL10 protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • S100 Calcium-Binding Protein A4
  • S100 Proteins
  • Interleukin-10
  • S100A4 protein, human
  • Uric Acid